Keyphrases
Diabetic Retinopathy
100%
Injectable Gel
100%
I-Corps
100%
Antiangiogenic
60%
Customer Discovery
40%
Standard of Care
40%
Business Model Canvas
40%
Socioeconomic Burden
20%
Vision Loss
20%
Clinical Translation
20%
Shear-responsive
20%
Marketing Approval
20%
Debilitating Disease
20%
Intraocular Injection
20%
Impact Review
20%
Well-being
20%
Therapeutic Approaches
20%
Biological Activity
20%
Peptide Hydrogel
20%
Vascular Endothelial Growth Factor
20%
Patient Comfort
20%
Posterior Segment Diseases
20%
Retinal Diseases
20%
Future Therapies
20%
Aqueous Media
20%
Responsive Hydrogels
20%
Vitreous Humor
20%
Implantable Biomaterials
20%
Technological Understanding
20%
Supramolecular Nanofibers
20%
Drug Injection
20%
Material Properties
20%
Infection Risk
20%
Intraocular Drugs
20%
Review Criteria
20%
Business Strategy
20%
Antibody Technology
20%
Current Therapeutics
20%
Commercial Potential
20%
Patient Compliance
20%
Nogo-A
20%
Intraocular Neovascularization
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antiangiogenic
100%
Diabetic Retinopathy
100%
Disease
66%
Vasculotropin
33%
Retina Disease
33%
Infection
33%
Visual Impairment
33%
Nanofiber
33%
Neovascularization (Pathology)
33%
Biological Activity
33%
Biomaterial
16%
Biomaterial
16%